Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator-Reference-Cited by-同舟云学术

Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator

Published:2014-04 Issue:1-2 Volume:387 Page:8-18
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Poutiainen Pekka K.,Huhtala Tuulia,Jääskeläinen Tiina,Petsalo Aleksanteri,Küblbeck Jenni,Kaikkonen Sanna,Palvimo Jorma J.,Raunio Hannu,Närvänen Ale,Peräkylä Mikael,Juvonen Risto O.,Honkakoski Paavo,Laatikainen Reino,Pulkkinen Juha T.

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference46 articles.

1. Dalton JT Structural basis for antagonism and resistance of bicalutamide in prostate cancer;Bohl;Proc. Natl. Acad. Sci. USA,2005

2. Collocation of androgen receptor gene mutations in prostate cancer;Buchanan;Clin. Cancer Res.,2001

3. Prostate cancer-from steroid transformations to clinical translation;Chang;Nat. Rev. Urol.,2012

4. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat. Med.,2004

5. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target;Chen;Lancet Oncol.,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective androgen receptor modulators: the future of androgen therapy?;Translational Andrology and Urology;2020-03

2. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications;Sexual Medicine Reviews;2019-01

3. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines;European Journal of Medicinal Chemistry;2016-05